Stuart J. Koelewijn

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer.

161Terbium-Labeled Gold Nanoparticles as Nanoscale Brachytherapy Agents Against Breast Cancer.

Journal: Materials (Basel, Switzerland)

Published: November 01, 2024

Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate.

Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate.

Journal: EJNMMI research

Published: October 16, 2015

Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.

Optimization of combined temozolomide and peptide receptor radionuclide therapy (PRRT) in mice after multimodality molecular imaging studies.

Journal: EJNMMI research

Published: September 15, 2015

Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts.

Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: August 31, 2015

In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.

In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: December 15, 2014

Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.

Optimized time-resolved imaging of contrast kinetics (TRICKS) in dynamic contrast-enhanced MRI after peptide receptor radionuclide therapy in small animal tumor models.

Journal: Contrast media & molecular imaging

Published: April 16, 2014

Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.

Inhibited osteoclastic bone resorption through alendronate treatment in rats reduces severe osteoarthritis progression.

Journal: Bone

Published: February 15, 2014

Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

Peptide receptor radionuclide therapy (PRRT) with [(177)Lu-DOTA(0),Tyr(3)]octreotate in combination with RAD001 treatment: further investigations on tumor metastasis and response in the rat pancreatic CA20948 tumor model.

Journal: EJNMMI research

Published: February 06, 2014

Increased physical activity severely induces osteoarthritic changes in knee joints with papain induced sulfate-glycosaminoglycan depleted cartilage.

Increased physical activity severely induces osteoarthritic changes in knee joints with papain induced sulfate-glycosaminoglycan depleted cartilage.

Journal: Arthritis research & therapy

Published: September 18, 2013

mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer.

mTOR inhibitor RAD001 promotes metastasis in a rat model of pancreatic neuroendocrine cancer.

Journal: Cancer research

Published: November 15, 2012

Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imaging.

Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imaging.

Journal: Molecular imaging

Published: March 16, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026